New Deputy Director for Impact Appointed
We are pleased to announce that Professor Michael Boniface has been appointed as TAS Deputy Director for Impact.
Michael is a Professorial Fellow of Information Technology and Director of the IT Innovation Centre within the School of Electronics and Computer Science, University of Southampton. He is a Director of the Web Science Institute, co-investigator for the Southampton Biomedical Research Centre Data Health and Society theme, and member of the executive leadership team at the NIHR Wessex Applied Research Centre.
Michael has 20+ years’ experience of applied research and innovation in federated systems management and data-driven research/innovation across healthcare, smart cities, engineering, telecommunications and creative industries. He is an expert in translational research through deep knowledge of digital innovation, acceleration methodologies, state-of-the-art data infrastructures, discovery pipelines and real-world testing. He has an international reputation as thought-leader pioneering the evolution of information technologies for tackling important business and societal challenges. He leads large scale international interdisciplinary research programmes and research hubs at the boundary of technology and society (healthcare, education, creative industries). For example, EXPERIMEDIA (2011-2015, €10.8M EUR) a multi-venue experimentation service supporting technology innovation through new forms of interaction and experience, FLAME (2017-2020, €6.2M) a large scale real-world (Bristol, Barcelona, London, Sicily) experimental facility for AR/VR services over 5G.
His AI healthcare programme is tackling challenges across public health, chronic disease management and integrated care. He leads AI research tackling the prevention of (MELD-B) and integrated care (health and social care) for multiple long term conditions (Cluster-AIM Study). He is Principal Investigator for the mySmartCOPD one of the first projects to undertake a national scale clinical trial of AI for self-management of a chronic disease, building on a feasibility study conducted as part of the H2020 BigMedilytics project. His rapid insight work “validating home oxygen saturations as a marker of clinical deterioration in patients with suspected COVID-19” supported the NHS through COVID Virtual Wards working with NHS partners across North Hampshire and informing national policies. The South East NHSX RECOxCARE programme that he initiated was scaled by Dr Matt Inada-Kim as the £60 million national COVIDoximetry@home and clinical model adopted by WHO. His AI decision support research for integrated care pathways continued with a focus on the challenge of complex discharge (PROCED) and supporting NHS winter pressures of Acute Respiratory Infections (PHILOSARIP) and Hospital Discharge (DS4SmartDischarge). His research includes a distinct focus on human centred AI and trust/trustworthiness of AI systems. As part of the UKRI Trustworthiness Autonomous System Hub he is laying the Foundations for Trustworthiness Risk Assessment of AI systems, whilst also tackling the challenge of codesigning AI systems with the public, patients and clinicians using computational notebooks as a design tool.